cst anti mek Search Results


95
Cell Signaling Technology Inc anti mek 1 2
Anti Mek 1 2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mek 1 2/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti mek 1 2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti p mek
Anti P Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p mek/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti p mek - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc p mek
P Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p mek/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
p mek - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc mek inhibitor u1026
Mek Inhibitor U1026, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek inhibitor u1026/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
mek inhibitor u1026 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc mek
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mek/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
mek - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc primary antibodies against erk, p-erk, mek, p-mek
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Primary Antibodies Against Erk, P Erk, Mek, P Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against erk, p-erk, mek, p-mek/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
primary antibodies against erk, p-erk, mek, p-mek - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc mouse anti mek
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Mouse Anti Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti mek/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
mouse anti mek - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti mek
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Anti Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mek/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
anti mek - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

90
Cell Signaling Technology Inc anti-mek
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Anti Mek, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-mek/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
anti-mek - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc anti p mitogen activated protein kinase
Acute 6-OH–BDE-47 exposure impairs <t>MEK–ERK</t> signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK <t>and</t> <t>pMEK</t> levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.
Anti P Mitogen Activated Protein Kinase, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p mitogen activated protein kinase/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
anti p mitogen activated protein kinase - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


Acute 6-OH–BDE-47 exposure impairs MEK–ERK signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK and pMEK levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.

Journal: The Journal of Biological Chemistry

Article Title: Certain ortho-hydroxylated brominated ethers are promiscuous kinase inhibitors that impair neuronal signaling and neurodevelopmental processes

doi: 10.1074/jbc.RA119.011138

Figure Lengend Snippet: Acute 6-OH–BDE-47 exposure impairs MEK–ERK signaling. A, top panel: synaptosomes were prepared from neurons acutely exposed (20 min pre-treatment) to 5 μm 6-OH with and without Bic + 4AP stimulus (10 min). Levels of the CaMK1 target pSynapsin1(serine 9) were assessed via Western blotting. n = 2. Bottom panel: to reproduce a previously reported effect linking CaMK1 to MEK–ERK activity (70), neurons were acutely exposed (60 min pre-treatment) to the CaMKK inhibitor STO-609 prior to treatment with Bic + 4AP for 10 min (indicated as +B10′). Inhibition of pERK induction was assessed by Western blotting and is quantified below. n = 3, p value generated by unpaired one-tailed t test. B, cells acutely exposed (20 min pre-treatment) to BDE-47 or one of its hydroxylated metabolites were stimulated with Bic + 4AP for 10 min before collecting whole-cell lysates. Activation of MEK–ERK signaling was assessed by Western blotting, measuring pERK and pMEK levels. Note, the lower band in the MEK panel is the ERK band visualized on the same blot. Quantification relative to total ERK and MEK is shown below representative blots. n = 3–6, p values generated by one-way ANOVA with post hoc LSD. pERK quantification: treatment F(7,22) = 9.822, p < 0.0001. pMEK quantification: treatment F(7,16) = 7.805, p = 0.0004. C, same experimental design as in B., but neurons were stimulated with TTX + PMA to induce MEK–ERK signaling synapse-independently. n = 3. pERK quantification: treatment F(7,16) = 37.95, p < 0.0001.

Article Snippet: Primary antibodies included the following antibodies: β-actin (Thermo Fisher Scientific, catalog no. AM4302, RRID:AB_2536382 ); H4 (CST catalog no. 2935, RRID:AB_1147658 ); pERK (CST catalog no. 4370, RRID:AB_2315112 ); ERK (CST catalog no. 4696, RRID:AB_390780 ); pMEK (CST catalog no. 9154, RRID:AB_2138017 ); MEK (CST catalog no. 2352, RRID:AB_10693788 ); synapsin1 (SySy catalog no. 106011, RRID:AB_2619772 );PSD-95 (NeuroMab catalog no. 75-028, RRID:AB_2292909 ); gephyrin (SySy catalog no. 147111, RRID:AB_887719 ); synaptotagmin6 (NeuroMab catalog no. 75-271, RRID:AB_11001830 ); and synaptophysin1(SySy catalog no. 101011, RRID:AB_887824 ).

Techniques: Western Blot, Activity Assay, Inhibition, Generated, One-tailed Test, Activation Assay